Home / Tag Archives: CRPC

Tag Archives: CRPC

October, 2018

July, 2018

January, 2018

December, 2017

September, 2017

June, 2017

  • 9 June

    Pfizer and Astellas’ Cancer Study Accelerated by Two Years

    TOKYO & NEW YORK–(BUSINESS WIRE)–Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE:PFE) announced today the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of XTANDI® (enzalutamide) in patients with non-metastatic (M0) …

February, 2017